Wednesday, April 4, 2018

Montreal, Canada-Based Drug Corp Valeant Pharmaceuticals Received a 4Q 2017 Earnings Increase of US$1.063 Bil Courtesy of the Existing US Federal Income Tax Debt Forgiveness Feature Embedded in the US Trump Tax Cuts Act ........................................................................................ It Also Had a 4Q 2017 Toll Tax Expense of $88 Mil